Insider · CIK 0002005755
Christine Ann Fox
Files at MREO (Mereo BioPharma Group plc). First filing -, latest -.
In brief
Christine Ann Fox files SEC Form 4 as CFO at MREO (Mereo BioPharma Group plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christine Ann Fox has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | AGrant or award Share Options (Right to buy)derivative | +315,750 | $0.00 | $0 | 315,750 | Feb 2, 2026 |
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | AGrant or award Share Options (Right to buy)derivative | +105,250 | $0.00 | $0 | 105,250 | Feb 2, 2026 |
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | AGrant or award Share Options (Right to buy)derivative | +280,000 | $0.00 | $0 | 280,000 | Feb 2, 2026 |
| Jan 25, 2025 | MREO Mereo BioPharma Group plc | AGrant or award Share Options (Right to buy)derivative | +262,000 | $0.00 | $0 | 262,000 | Jan 28, 2025 |
Questions about Christine Ann Fox
Answered from the filings on this page, as of the latest one.
Is Christine Ann Fox buying or selling?
Christine Ann Fox has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christine Ann Fox's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christine Ann Fox has 0.
Where does Christine Ann Fox file Form 4?
Christine Ann Fox has filed Form 4 at MREO (Mereo BioPharma Group plc) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.